Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085

Blood (2019) 134 (Supplement_1): 130.

https://doi.org/10.1182/blood-2019-126787

Published: 2019

Journal Articles

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Ethel Cesarman, MD PhD, Mikhail Roshal, MD PhD, Jonathan Reichel, PhD, Wagner Florian, PhD, Bhavneet Binder, Sakellarios Zairis, Jouliana Sadek, PhD, Joshua Brody, MD, Raul Rabadan, PhD, Sandeep Dave, MD

Blood (2019) 134 (Supplement_1): 549.

https://doi.org/10.1182/blood-2019-131163

Published: 2019

Journal Articles

Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome

Nevin Yusufova, Matthew R Teater, PhD, Alexey Soshnev, Andreas Kloetgen, Adewola Osunsade, Joseph Conway, Ashley Doane, Arthur Skoultchi, Aristotelis Tsirigos, PhD, Yael David, C. David Allis, PhD, Ethel Cesarman, MD PhD, Ari Melnick, MD

Blood (2019) 134 (Supplement_1): 23.

https://doi.org/10.1182/blood-2019-127774

Published: 2019

Journal Articles

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Juan Carlos Ramos, MD BS, Joseph Sparano, MD, Page C. Moore, PhD, Eric Siegel, Jeannette Y Lee, PhD, Erin G. Reid, MD MS, Richard F. Ambinder, MD, Amy Chadburn, MD, Paul G. Rubinstein, MD, Christine Durand, Ethel Cesarman, MD PhD, Lee Ratner, MD PhD, Robert A Baiocchi, MD PhD, David M. Aboulafia, MD, Lawrence D Kaplan, MD, Adam Capoferri, Ronald T. Mitsuyasu, MD, Ariela Noy, MD

Blood (2019) 134 (Supplement_1): 1588.

https://doi.org/10.1182/blood-2019-129687

Published: 2019

Journal Articles

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma

Juan Carlos Ramos, MD BS, Richard F. Ambinder, MD, Joseph Sparano, MD, Jeannette Y Lee, PhD, Lawrence D Kaplan, MD, William Wachsman, MD PhD, David M. Aboulafia, MD, Ariela Noy, MD, Lee Ratner, MD PhD, David H. Henry, MD, Amy Chadburn, MD, Ethel Cesarman, MD PhD, Ronald T. Mitsuyasu, MD

Blood (2019) 134 (Supplement_1): 2872.

https://doi.org/10.1182/blood-2019-123558

Published: 2019

Journal Articles

Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL Subtypes

Destini Gibbs, Herman Van Besien, BA, Stephenson Regan, Ankur Singh, PhD, Matthew Teater, Ethel Cesarman, MD PhD, Ari Melnick, MD, Lisa Giulino Roth, MD

Blood (2019) 134 (Supplement_1): 304.

https://doi.org/10.1182/blood-2019-126790

Published: 2019

Journal Articles

Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset

Samuel Yamshon, MD, Miguel Dario Cantu, Ethel Cesarman, MD PhD, Sarah C. Rutherford, MD, Amy Chadburn, MD, Genevieve Marie Crane, MD PhD

Blood (2019) 134 (Supplement_1): 2792.

https://doi.org/10.1182/blood-2019-128374

Published: 2019

Journal Articles

AMC075: The Combination of Vorinostat with Chemotherapy and Rituximab Is Tolerable and Feasible in HIV-Related B-Cell Non-Hodgkin’s Lymphoma with High-Risk Features

Juan Carlos Ramos, MD, Joseph Sparano, MD, Page Moore, Jeannette Y. Lee, Michelle A Rudek, Richard F. Ambinder, Ethel Cesarman, MD PhD, Ariela Noy, MD, Ronald T. Mitsuyasu, MD

Blood (2014) 124 (21): 4473.

https://doi.org/10.1182/blood.V124.21.4473.4473

Published: 2014

Journal Articles

Microenvironment Assessment, Disease Characteristics and Prognosis In HIV-Associated (HIV-cHL) and HIV-Negative Classical Hodgkin Lymphoma: The Influence Of Epstein Barr Virus (EBV)

Paul G. Rubinstein, MD, Shylendra Sreenivasappa, MD, Marina Messinger, MD, Adam M. Petrich, MD, Jonathan Moreira, MD, Locke J. Bryan, MD, Victoria Angelova, MD, Shweta Gupta, MD, Ariela Noy, MD, Ingrid Sumpter, BS, Ethel Cesarman, MD, PhD, Amy Chadburn, M.D.

Blood (2013) 122 (21): 2996.

https://doi.org/10.1182/blood.V122.21.2996.2996

Published: 2013

Journal Articles

Characterizing The CpG Methylation Of Epstein-Barr Virus DNA In The Plasma Of Patients With Hodgkin Lymphoma and HIV-Associated Burkitt Lymphoma

Jennifer A. Kanakry, Meir Shamay, Yvette L. Kasamon, Hailun Li, MS, Randy D. Gascoyne, MD, Leo I. Gordon, MD, Ariela Noy, MD, Ethel Cesarman, MD, PhD, Jeannette Y Lee, Ph.D., Sandra J. Horning, MD, Richard F. Ambinder

Blood (2013) 122 (21): 4232.

https://doi.org/10.1182/blood.V122.21.4232.4232

Published: 2013

Journal Articles

Exome Sequencing Of Purified Hodgkin Reed-Sternberg Cells Reveals Recurrent Somatic Mutations In Genes Responsible For Antigen Presentation, Chromosome Integrity, Transcriptional Regulation and Protein Ubiquitination

Jonathan B. Reichel, Kenneth Eng, Olivier Elemento, PhD, Ethel Cesarman, MD, PhD, Mikhail Roshal, MD, PhD

Blood (2013) 122 (21): 625.

https://doi.org/10.1182/blood.V122.21.625.625

Published: 2013

Journal Articles

Identification of a Novel Inhibitor That Selectively Targets NF-κB Activity in KSHV-Infected Lymphoma Cells

Utthara Nayar, PhD, Gunkut Akar, Robert H Shoemaker, PhD, Shizuko Sei, MD, Ethel Cesarman, MD, PhD

Blood (2012) 120 (21): 160.

https://doi.org/10.1182/blood.V120.21.160.160

Published: 2012

Journal Articles

Novel Genomic Alterations in MCL1 and ARID1A Identified in Pediatric Burkitt Lymphoma Using Targeted High-Throughput Sequencing

Blood (2012) 120 (21): 899.

https://doi.org/10.1182/blood.V120.21.899.899

Published: 2012

Journal Articles

The Viral Oncoprotein vFLIP Encoded by KSHV/HHV-8 Is Responsible for the Unique Transcriptional Signature and Phenotypic Features of Primary Effusion Lymphoma

Ilaria Guasparri, PhD, Duane C Hassane, PhD, Mikhail Roshal, MD, PhD, Ethel Cesarman, MD, PhD

Blood (2012) 120 (21): 900.

https://doi.org/10.1182/blood.V120.21.900.900

Published: 2012

Journal Articles

TNFAIP3 (A20) Genetic Alterations In EBV Associated AIDS Related Lymphomas

Lisa B. Giulino, MD, Susan Mathew, PhD, Wayne Tam, MD, PhD, Amy Chadburn, MD, Gianna Ballon, Sharon Barouk, Giuseppina Antonicelli, Lorenzo Leoncini, Ethel Cesarman, MD, PhD

Blood (2010) 116 (21): 802.

https://doi.org/10.1182/blood.V116.21.802.802

Published: 2010

Journal Articles

Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis

Gianna Ballon, MD, Amy Chadburn, MD, Rocio Perez, MA, Yi-Fang Liu, MD, Yoshiteru Sasaki, MD, PhD, Ethel Cesarman, MD, PhD

Blood (2008) 112 (11): 81.

https://doi.org/10.1182/blood.V112.11.81.81

Published: 2008

Journal Articles

Deregulation of c-Myc in Primary Effusion Lymphoma by KSHV LANA.

Darya Bubman, MS, Ilaria Guasparri, PhD, Ethel Cesarman, MD PhD

Blood (2006) 108 (11): 4347.

https://doi.org/10.1182/blood.V108.11.4347.4347

Published: 2006

Journal Articles

LMP1, LMP2A and CD40 Are All Essential for EBV-Associated Lymphoma Cell Survival.

Ilaria Guasparri, PhD, Ethel Cesarman, MD-pHD

Blood (2006) 108 (11): 4353.

https://doi.org/10.1182/blood.V108.11.4353.4353

Published: 2006

Journal Articles

Neither Germinal Center (GC) vs Non-Germinal Center (Non-GC) Phenotype nor FOXP1 Expression Correlate with Outcome in AIDS-Associated Diffuse Large B-Cell Lymphoma (DLBCL): Study of Patients from AIDS Malignancies Consortium Trials 010 and 034.

Amy Chadburn, MD, Xia Chen, MD PhD, April Chiu, MD, Elizabeth Hyjek, MD PhD, Wayne Tam, MD PhD, Lawrence Kaplan, MD, David T. Scadden, MD, Daniel M. Knowles, MD, Ethel Cesarman, MD PhD

Blood (2006) 108 (11): 2023.

https://doi.org/10.1182/blood.V108.11.2023.2023

Published: 2006

Journal Articles

Reactive Oxygen Species (ROS) Are Induced by vFLIP and Regulate NF-kB Activation in KSHV-Infected Primary Effusion Lymphoma Cells.

Darya Bubman, MS, Balazs Csernus, MD, Ilaria Guasparri, PhD, Ethel Cesarman, MD, PhD

Blood (2005) 106 (11): 992.

https://doi.org/10.1182/blood.V106.11.992.992

Published: 2005

NARROW

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma

Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL Subtypes

Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset

AMC075: The Combination of Vorinostat with Chemotherapy and Rituximab Is Tolerable and Feasible in HIV-Related B-Cell Non-Hodgkin’s Lymphoma with High-Risk Features

Microenvironment Assessment, Disease Characteristics and Prognosis In HIV-Associated (HIV-cHL) and HIV-Negative Classical Hodgkin Lymphoma: The Influence Of Epstein Barr Virus (EBV)

Characterizing The CpG Methylation Of Epstein-Barr Virus DNA In The Plasma Of Patients With Hodgkin Lymphoma and HIV-Associated Burkitt Lymphoma

Exome Sequencing Of Purified Hodgkin Reed-Sternberg Cells Reveals Recurrent Somatic Mutations In Genes Responsible For Antigen Presentation, Chromosome Integrity, Transcriptional Regulation and Protein Ubiquitination

Identification of a Novel Inhibitor That Selectively Targets NF-κB Activity in KSHV-Infected Lymphoma Cells

Novel Genomic Alterations in MCL1 and ARID1A Identified in Pediatric Burkitt Lymphoma Using Targeted High-Throughput Sequencing

The Viral Oncoprotein vFLIP Encoded by KSHV/HHV-8 Is Responsible for the Unique Transcriptional Signature and Phenotypic Features of Primary Effusion Lymphoma

TNFAIP3 (A20) Genetic Alterations In EBV Associated AIDS Related Lymphomas

Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis

Deregulation of c-Myc in Primary Effusion Lymphoma by KSHV LANA.

LMP1, LMP2A and CD40 Are All Essential for EBV-Associated Lymphoma Cell Survival.

Neither Germinal Center (GC) vs Non-Germinal Center (Non-GC) Phenotype nor FOXP1 Expression Correlate with Outcome in AIDS-Associated Diffuse Large B-Cell Lymphoma (DLBCL): Study of Patients from AIDS Malignancies Consortium Trials 010 and 034.

Reactive Oxygen Species (ROS) Are Induced by vFLIP and Regulate NF-kB Activation in KSHV-Infected Primary Effusion Lymphoma Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only